Toxicity of combined targeted therapy and concurrent radiotherapy in metastatic melanoma patients: a single-center retrospective analysis

The Eastern Cooperative Oncology Group consensus guidelines from 2016 recommend interruption of targeted therapy with BRAF- and MEK-inhibitors during radiotherapy with data being based mostly on BRAF monotherapy. The aim of this study is to provide data on the safety of concurrent radiotherapy and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziegler, Johanna S., Kroeze, Stephanie, Hilbers, Marie-Luise, Imhof, Laurence, Guckenberger, Matthias, Levesque, Mitchell P., Dummer, Reinhard, Cheng, Phil, Mangana, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles: Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643789/
https://www.ncbi.nlm.nih.gov/pubmed/32658050
http://dx.doi.org/10.1097/CMR.0000000000000682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643789/
https://www.ncbi.nlm.nih.gov/pubmed/32658050
http://dx.doi.org/10.1097/CMR.0000000000000682

Ejemplares similares